EV-201

Seagen, Astellas report positive results from PADCEV phase 2 trial in advanced urothelial cancer
Pharmaceutical Business Review
Tue, 10/13/20 - 11:08 am
Seagen
Astellas
clinical trials
EV-201
urothelial cancer